Monoclonal antibodies (mAbs) are a focus in vaccine and therapeutic design to counteract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ......
Scheid, JF; Barnes, CO; Eraslan, B; Hudak, A; Keeffe, JR; Cosimi, LA; Brown, EM; Muecksch, F; Weisblum, Y; Zhang, ST; Delorey, T; Woolley, AE; Ghantous, F; Park, SM; Phillips, D; Tusi, B; Huey-Tubman, KE; Cohen, AA; Gnanapragasam, PNP; Rzasa, K; Hatziioanno, T; Durney, MA; Gu, XB; Tada, T; Landau, NR; West, AP; Rozenblatt-Rosen, O; Seaman, MS; Baden, LR; Graham, DB; Deguine, J; Bieniasz, PD; Regev, A; Hung, D; Bjorkman, PJ; Xavier, RJ
Xavier, RJ (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Harvard Univ, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Bi
CELL, 2021; 184 (12): 3205